Replies to post #1611 on Spectrum Pharmaceutecals Inc (SPPI)

[stugwins]

Have no idea how he came up with $9M being 35% of melphalan market. All databases I have report only 3 alkylating agents above $100M. These are Bendamustine, Cyclophosphamide, Temodar. Valchlor (i.e. papa mustard in it's newest incarnation) seems to be pushing the $50-$60M mark but all else is below this.

Any references/thoughts?